Old Web
English
Sign In
Acemap
>
authorDetail
>
Johnathan Maher
Johnathan Maher
Dendreon
Medicine
Sipuleucel-T
Prostate cancer
Androgen deprivation therapy
Asymptomatic
5
Papers
67
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
2017
Clinical Cancer Research
Emmanuel S. Antonarakis
Adam S. Kibel
Evan Y. Yu
Lawrence Karsh
Aymen Elfiky
Neal D. Shore
Nicholas J. Vogelzang
John M. Corman
Frederick Millard
Johnathan Maher
Nancy N. Chang
Todd DeVries
Nadeem A. Sheikh
Charles G. Drake
Show All
Source
Cite
Save
Citations (46)
Immune responses and clinical outcomes in STAND, a randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (sip-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC) after local therapy failure.
2015
Journal of Clinical Oncology
Emmanuel S. Antonarakis
Adam S. Kibel
George W. Adams
Lawrence Karsh
Aymen Elfiky
Neal D. Shore
Nicholas J. Vogelzang
John M. Corman
Johnathan Maher
Todd DeVries
Candice McCoy
Nadeem A. Sheikh
Charles G. Drake
Show All
Source
Cite
Save
Citations (6)
MP87-15 RANDOMIZED PHASE 2 STUDY EVALUATING OPTIMAL SEQUENCING OF SIPULEUCEL-T AND ANDROGEN DEPRIVATION THERAPY (STAND) IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: PRELIMINARY CLINICAL OUTCOMES
2015
The Journal of Urology
Adam S. Kibel
Charles G. Drake
George G. Adams
Lawrence Karsh
Aymen Elfiky
Neal D. Shore
Nicholas J. Vogelzang
John M. Corman
Robert C. Tyler
Johnathan Maher
Todd DeVries
Nadeem A. Sheikh
Emmanuel S. Antonarakis
Show All
Source
Cite
Save
Citations (0)
Preliminary product parameter and safety results from NeuACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+ urothelial cancer at high risk for recurrence.
2014
Journal of Clinical Oncology
Dean F. Bajorin
Leonard G. Gomella
Padmanee Sharma
Elizabeth R. Plimack
Peter H. O’Donnell
Jean H. Hoffman-Censits
Thomas W. Flaig
David I. Quinn
Dwayne Campogan
Heather Haynes
Candice McCoy
Johnathan Maher
Todd DeVries
Nadeem A. Sheikh
Seth P. Lerner
Show All
Source
Cite
Save
Citations (6)
An analysis of leukapheresis and central venous catheter use in the randomized, placebo controlled, phase 3 IMPACT trial of Sipuleucel-T for metastatic castrate resistant prostate cancer.
2013
The Journal of Urology
Robert C. Flanigan
Anthony J. Polcari
Neil Shore
Thomas H. Price
Robert B. Sims
Johnathan Maher
James Boyd Whitmore
John M. Corman
Show All
Source
Cite
Save
Citations (9)
1